DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Aakaar Medical Technologies Limited — Outcome of Board Meeting

NSE 1 hr ago·30 Oct 2026, 12:18 pm

Aakaar Medical Technologies

Aakaar Medical Technologies held a board meeting and subsequently filed its financial results for the quarter ended September 30, 2026 with the stock exchange.

The filing provides investors with a snapshot of the company’s recent performance, covering revenue, profit, cash flow and any changes in capital structure. Reviewing these metrics helps gauge whether the firm is meeting its growth targets and maintaining financial health, which can influence market sentiment.

Investors should examine the detailed results when they are released, watch for management commentary on future guidance, and stay alert for upcoming events such as earnings calls or dividend announcements that could affect the stock.